1. SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization;Baine;J. Thorac. Oncol.,2020
2. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial;Baize;Lancet Oncol.,2020
3. A decade of exploring the cancer epigenome — biological and translational implications;Baylin;Nat. Rev. Cancer 2011 11:10,2011
4. Different levels of Twist1 regulate skin tumor initiation, stemness, and progression;Beck;Cell Stem Cell,2015
5. Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models;Belgiovine;Br. J. Cancer,2017